A Multiple Arm, Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis
Latest Information Update: 12 Sep 2023
At a glance
- Drugs PTP-001 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bioventus
- 25 Dec 2022 This trial has been completed in Denmark (End Date: 8 Nov 2022) according to European Clinical Trials Database record.
- 18 Jul 2022 Status changed from recruiting to active, no longer recruiting.
- 03 Nov 2021 New trial record